| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/25/2006 | US20060111314 Method for treating or preventing metastasis of colorectal cancers |
| 05/25/2006 | US20060111313 modulating calvarial osteoblast differentiation and mineralization in human by altering expression or activity of Nell-1 in human, wherein increased expression or activity of Nell-1 increases osteoblast differentiation or mineralization and decreased expression decreases osteoblast differentiation |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060110827 nucleic acid encoding a phytochrome protein comprising a mutation in the P3 GAF domain; cyanobacterial phytochrome |
| 05/25/2006 | US20060110803 Antigenic peptides of SARS coronavirus and uses thereof |
| 05/25/2006 | US20060110794 Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 05/25/2006 | US20060110792 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 05/25/2006 | US20060110787 Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection |
| 05/25/2006 | US20060110786 kits for discriminating between COX-1 and COX-2 activity; screening for a tumor, monitoring anticancer treatment or antiinflammatory treatment; less invasive; 2-arachidonylglycerol is a substrate of the COX-2 enzyme, but not COX-1 |
| 05/25/2006 | US20060110785 Methods to differentiate protein conformers |
| 05/25/2006 | US20060110784 Site-specific labeling of proteins for NMR studies |
| 05/25/2006 | US20060110783 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) |
| 05/25/2006 | US20060110782 cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling |
| 05/25/2006 | US20060110781 Cholesterol detection reagent |
| 05/25/2006 | US20060110773 Marker for inflammatory conditions |
| 05/25/2006 | US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients |
| 05/25/2006 | US20060110769 Regulation of novel human prolyl 4-hydroxylases |
| 05/25/2006 | US20060110768 contacting a viable murine myoblast test cell with test compound, determining the change in expression level of a murine indicator gene selected from the group consisting of 4833427G06 Rik (RIKEN cDNA) and murine Dda3 (Differential display and activated by p53) |
| 05/25/2006 | US20060110767 Genotyping assay to predict cytochrome P4503A5 exression |
| 05/25/2006 | US20060110766 Method of determining a cellular response to a biological agent |
| 05/25/2006 | US20060110765 Detection of nucleic acid variation by cleavage-amplification (CleavAmp) method |
| 05/25/2006 | US20060110764 Large-scale parallelized DNA sequencing |
| 05/25/2006 | US20060110763 Nucleic acid preparation |
| 05/25/2006 | US20060110762 Porcine reproductive and respiratory syndrome virus receptor components and uses thereof |
| 05/25/2006 | US20060110761 Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof |
| 05/25/2006 | US20060110760 Microarray using laminar flow and method of preparing the same |
| 05/25/2006 | US20060110759 Detecting genomic DNA in tumor sample; drug screening |
| 05/25/2006 | US20060110758 Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof |
| 05/25/2006 | US20060110757 Method of designing probe from polynucleotide group comprising plurality of polynucleotides |
| 05/25/2006 | US20060110756 Large-scale parallelized DNA sequencing |
| 05/25/2006 | US20060110755 Hepatitis c viral fusion protein comprising stablilizing peptides for use in developing vaccines to prevent and treat hepatitis viral infection |
| 05/25/2006 | US20060110754 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
| 05/25/2006 | US20060110753 Methods to diagnose and treat lung cancer |
| 05/25/2006 | US20060110752 Analyzing the hybridization intensities, by using oligonucleotide probes, which is complementary to target nucleic acid sequence, using principal component analysis; genetic engineering ; rapid efficient method for analyzing polymorphic or biallelic markers |
| 05/25/2006 | US20060110751 Method and kit for detecting a risk of essential arterial hypertension |
| 05/25/2006 | US20060110750 Structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations |
| 05/25/2006 | US20060110749 Primer composition and method of using the same in the detection of Shigella sonnei |
| 05/25/2006 | US20060110748 Methods for detection of a nucleic acid by sequential amplification |
| 05/25/2006 | US20060110747 Process for improved protein expression by strain engineering |
| 05/25/2006 | US20060110746 Treatment of cancer using TLR3 agonists |
| 05/25/2006 | US20060110745 Method for amplifying nucleic acids |
| 05/25/2006 | US20060110744 Probe design methods and microarrays for comparative genomic hybridization and location analysis |
| 05/25/2006 | US20060110742 Carrier tests for polycystic kidney disease in the cat |
| 05/25/2006 | US20060110741 Nucleic acid methylation detection process using an internal reference sample |
| 05/25/2006 | US20060110740 Use of sendai virus as a human parainfluenza vaccine |
| 05/25/2006 | US20060110739 Biosensors for detecting macromolecules and other analytes |
| 05/25/2006 | US20060110738 Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor |
| 05/25/2006 | US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
| 05/25/2006 | US20060110736 Hiv vaccine formulations |
| 05/25/2006 | US20060110735 Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 05/25/2006 | US20060110734 conducting a bioassay on a DNA sample or an RNA sample, to determine the presence or absence of gene mutations associated with a genetic disorder with clinical features including exocrine pancreatic insufficiency, haematological dysfunction and skeletal abnormalities |
| 05/25/2006 | US20060110733 Coded nucleic acid carriers |
| 05/25/2006 | US20060110732 Method for the identification of ligands |
| 05/25/2006 | US20060110731 Cancer-linked gene as target for chemotherapy |
| 05/25/2006 | US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/25/2006 | US20060110729 Method of dna testing for mycobacterium paratuberculosis strains |
| 05/25/2006 | US20060110728 Supported double layer structure for displaying a nucleic acid associated with a protein |
| 05/25/2006 | US20060110727 Incorporating a base selected from the group consisting of 7-deazaguanosine, 2-aminopurine, 8-aza-7-deazaguanosine, 1H-purine, and hypoxanthine into the oligonuclotide of the oligonuleotide array |
| 05/25/2006 | US20060110726 Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acouired immunodeficiency syndrome |
| 05/25/2006 | US20060110725 Apparatus for and method of purifying nucleic acids by different laser absorption of beads |
| 05/25/2006 | US20060110724 Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard |
| 05/25/2006 | US20060110723 Multiplexed protein expression and activity assay |
| 05/25/2006 | US20060110722 microfluidic-based cell mimic platform for biomolecular studies and a method of mimicking the environment within a cell utilizing the platform |
| 05/25/2006 | US20060110407 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 05/25/2006 | US20060110405 Plasma or serum fraction for treatment and prevention of viral infections and related conditions |
| 05/25/2006 | US20060110404 Set of ubiquitous cellular proteins involved in viral life cycle |
| 05/25/2006 | US20060110397 Protein of given amino acid sequence; yeast-two-hybrid assay screening for agent which inhibits formation of heterodimer and gene expression; diagnosis and treatment of cancer |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity |
| 05/25/2006 | US20060110385 Means and methods for diagnosing and treating affective disorders |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110381 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin |
| 05/25/2006 | US20060110372 Regulatory cells that control T cell immunoreactivity |
| 05/25/2006 | US20060108219 Chemical sensor and chemical sensor apparatus |
| 05/25/2006 | CA2521207A1 Expression cassettes for guard cell-preferential expression in plants |
| 05/24/2006 | EP1659403A2 Method of screening candidate compounds for susceptibility to biliary excretion |
| 05/24/2006 | EP1659187A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of HSV DNA and method for the amplification and detection of HSV DNA using a transcription based amplification |
| 05/24/2006 | EP1659186A1 A method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids |
| 05/24/2006 | EP1659185A1 Genetical test of deafness in dogs |
| 05/24/2006 | EP1659184A1 Genetic test for strabism in cattle |
| 05/24/2006 | EP1659183A1 Real-time quantification of multiple targets on a micro-array |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659170A1 Nucleic acid amplifier and method of nucleic acid amplification |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1658898A1 Nucleic acid preparation |
| 05/24/2006 | EP1658506A2 Methods for reducing complexity of a sample using small epitope antibodies |
| 05/24/2006 | EP1658504A1 Inhibition of s6 kinase activity for the treatment of insulin resistance |
| 05/24/2006 | EP1658492A1 Reaction conditions sensor |
| 05/24/2006 | EP1658384A2 Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids |
| 05/24/2006 | EP1658383A1 Improved bisulfite method employing size exclusion step |
| 05/24/2006 | EP1658382A1 Multi-allelic molecular detection of sars-associated coronavirus |
| 05/24/2006 | EP1658381A2 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching |
| 05/24/2006 | EP1658380A2 Method for determining hair cycle markers |
| 05/24/2006 | EP1658379A2 Human obesity susceptibility gene and uses thereof |
| 05/24/2006 | EP1658378A2 Active-site titration of glycosyl hydrolases |
| 05/24/2006 | EP1658374A1 Methods and compositions for amplification of dna |
| 05/24/2006 | EP1658364A2 Tubulin regulatory elements for use in plants |
| 05/24/2006 | EP1658307A2 Methods for the early diagnosis of ovarian cancer |
| 05/24/2006 | EP1658303A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/24/2006 | EP1658094A1 C1-inh as a drug for treating viruses pathogenic to humans |